title: SEOM clinical guidelines for the management of metastatic breast cancer 2013.
abstract: Patients with metastatic breast cancer should be offered comprehensive and personalized medical attention including, but not limited to, psychosocial, supportive and symptom-related interventions. A large number of treatment options are available and several prognostic and predictive factors are useful to identify the best therapeutic options individually.
authors.affiliation: Servicio de Oncología Médica, Hospital Arnau de Vilanova, C/San Clemente, 12, 46015, Valencia, Spain, antonio.llombart@medsir.org.
authors.forename: A
authors.initials: A
authors.lastname: Llombart Cussac
authors.forename: J
authors.initials: J
authors.lastname: de la Haba Rodríguez
authors.forename: A
authors.initials: A
authors.lastname: Ruiz Simón
authors.forename: I
authors.initials: I
authors.lastname: Álvarez López
authors.forename: J
authors.initials: J
authors.lastname: Cortés Castán
mesh_terms: D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use; D001859:Bone Neoplasms / Q000556:secondary / Q000628:therapy; D001943:Breast Neoplasms / Q000235:genetics / Q000473:pathology* / Q000628:therapy*; D016543:Central Nervous System Neoplasms / Q000556:secondary / Q000628:therapy; D017024:Chemotherapy, Adjuvant; D005260:Female; D018734:Genes, erbB-2; D006801:Humans; D020360:Neoadjuvant Therapy; D009362:Neoplasm Metastasis; D017698:Postmenopause; D011960:Receptors, Estrogen / Q000235:genetics; D012008:Recurrence
chemical_list: D018931:Antineoplastic Agents, Hormonal; D011960:Receptors, Estrogen